Bacchus Therapeutics
- Biotech or pharma, therapeutic R&D
Stanford-startup with proprietary small molecules that targets a first-in-class target, which starves MYC cancers (especially kidney, liver, and lymphomas) of lipids and cause MYC cancer regression and prolongs survival in both primary transgenic mouse models as well as PDX models.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}